Health Care Equipment & Services

Quest Diagnostics CFO’s fresh buy amid a strong earnings surge signals insider confidence, underscoring the company’s growth plans in automation and analytics.

Lucid Diagnostics insider holding signals long‑term confidence, fresh capital, and a strong, value‑based reimbursement strategy for its ctDNA esophageal cancer test.

Insider buying, dividend policy, and digital health initiatives reveal why Cigna’s stock is gaining confidence amid market volatility and regulatory changes.

Procept Biorobotics insider holdings reveal mixed confidence—executive stability amid volatile shares, yet buying signals potential upside in minimally invasive urology.

Insider buying at NHC signals long‑term confidence: Vicki Dodson adds 4,000 shares at $94.10, boosting her stake amid strategic growth and a 52‑week high of $184.08.

HeartBeam’s insider buying surge after its IPO signals CEO‑candidate Ferrari Richard’s confidence and may hint at future upside, but investors should watch for consistent growth.

Avanos Medical CFO’s April 22 sale: a tax‑withholding move, not a warning. Learn how AIP’s pending acquisition could boost the medical‑device stock’s future.

OneMedNet insider buys signal confidence: executives purchase millions of shares at fair value, hinting at future upside in AI‑driven healthcare analytics.

Explore SBC Medical Group’s insider sale and call‑option purchase—understand its liquidity strategy, market impact, and tech‑driven growth plan.

Insider sale by LifeStance’s Robert Bessler shows routine rebalancing, not distress—investors should watch future earnings and value‑based reimbursement trends.